Long-term regression of experimental endometriosis in a rat model treated with local application of levonorgestrel-loaded biodegradable microspheres
Lab / animal
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
Local application of levonorgestrel-loaded microspheres induced long-term regression of endometriotic cysts in rats for one year, comparable to GnRH agonist treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: A previous study demonstrated that local application of levonorgestrel-loaded polylactic acid microspheres (LNG microspheres) resulted in significant regression of endometriotic cysts in a rabbit model for 6 months without disturbing the metabolic parameters or ovarian function. In order to investigate the feasibility of local application of LNG microspheres as a long-term maintenance treatment for endometriosis, the suppressive effect of a single intra-cystic injection of LNG microspheres was studied for 1 year in a rat model.
METHODS AND RESULTS: Twenty four rats with experimental endometriotic cysts were randomized to be treated with a single intra-cystic injection of LNG microspheres (n = 8); 6-month GnRH agonist (GnRHa, n = 8) or control (n = 8). Intra-cystic injection of LNG microspheres and GnRHa treatment caused comparable regression and atrophy in endometriotic cysts in the first 6 months. Compared with the control, the wet weight of the endometriotic cysts was significantly lower in both groups at Month 6 but by Month 12 only remained low in the LNG microspheres group (P < 0.01). The immunostaining of estrogen receptors (ERs) in both the epithelium and stroma and progesterone receptors (PRs) in the stroma was significantly weakened in the LNG microspheres group at Month 6 and was not fully restored at Month 12 (P < 0.01). Metabolic parameters and estrous cycle were not disturbed by local application of LNG microspheres.
CONCLUSIONS: In a rat endometriosis model, the suppressive effect of a single intra-cystic injection of LNG microspheres was comparable to that of GnRHa, and was maintained for 1 year. The down-regulation of ERs and PRs might serve as possible mechanism of long-term effectiveness.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (20)
- Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis via openalex
- Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium via openalex
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
- Induction of a local pseudo-pregnancy for the treatment of endometriosis via openalex
- Induction of a local pseudo-pregnancy via levonorgestrel-loaded microspheres for the treatment of endometriosis in a rabbit model via openalex
- Progesterone receptor isoform A but not B is expressed in endometriosis via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up via openalex
- Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis via openalex
- Receptor concentrations for estradiol and progesterone in surgically induced endometriosis in the rat via openalex
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W2346020725 via openalex
- W1971586374 via openalex
- W1981344902 via openalex
- W2067050766 via openalex
- W2074845402 via openalex
- W2123134517 via openalex
- W2132577372 via openalex
- W2284473629 via openalex
- W1756838878 via openalex
Cited by (5)
- Biomaterials for women's health: Recent progress in nanomaterials and innovative therapies for endometriosis treatment 2026
- WITHDRAWN: Endometriosis related sex steroid hormones, hypothalamic pituitary gonadal axis hormones and related animal modeling: A comprehensive review of published articles and endometriosis induction methods from 2010 to 2021 with scoring based approach 2021
- Interplay between Endometriosis and Pregnancy in a Mouse Model 2015
- Endometriosis in Experimental Models 2014
- Inducing malignant transformation of endometriosis in rats by long-term sustaining hyperestrogenemia and type II diabetes 2014
Source provenance
- europepmc
- last seen: 2026-10-18T09:30:06.152893+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:10:20.980095+00:00
- unpaywall
- last seen: 2026-10-18T06:28:46.490043+00:00
License: CC0
· commercial use OK